Home›Stock Screener›Mankind Pharma›Shareholding Pattern

Mankind Pharma Shareholding Pattern

As of Mar 2026, Mankind Pharma (MANKIND) promoter holding 72.66%, FII 10.24%, DII 14.46%, public 1.39%, total shareholders 177,606. Review MANKIND P/E ratio to evaluate earnings-based valuation against sector peers.

Promoter Holding 72.66%
FII Holding 10.24%
DII Holding 14.46%
Public Holding 1.39%
Total Shareholders 177,606
As of Mar 2026

MANKIND Recent Shareholding Changes — Promoter, FII & DII

Mankind Pharma promoter, FII and DII holding change from Dec 2025 to Mar 2026, FII -1.1%, DII +1.21%. For live price, key ratios and the full company profile, see MANKIND screener.

Promoter Holding Change
Dec 2025 to Mar 2026
No Change
FII Holding Change
Dec 2025 to Mar 2026
-1.1%
DII Holding Change
Dec 2025 to Mar 2026
+1.21%
Public Holding Change
Dec 2025 to Mar 2026
-0.13%

Mankind Pharma Quarterly Shareholding Trend — Promoter, FII, DII & Public

MANKIND promoter, FII, DII, public and government holding % by quarter — institutional ownership and promoter pledge trends. Check MANKIND market capitalization to track the company's total market size over time.

Promoter
FII
DII
Public
Government

MANKIND Shareholding Pattern Data — Quarterly History

Mankind Pharma quarterly promoter, FII, DII, public holding % and total shareholders. Download as Excel or CSV.

Period Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Mar 2026 72.66% 10.24% 14.46% 0.00% 1.39% 1.25% 100.00% 177,606
Dec 2025 72.66% 11.34% 13.25% 0.00% 1.52% 1.23% 100.00% 177,539
Sept 2025 72.67% 12.84% 11.92% 0.00% 1.36% 1.21% 100.00% 170,347
Jun 2025 72.68% 13.07% 11.50% 0.00% 1.52% 1.23% 100.00% 179,549
Mar 2025 72.70% 12.92% 11.48% 0.00% 1.64% 1.26% 100.00% 180,597
Dec 2024 72.71% 13.34% 11.06% 0.00% 1.60% 1.30% 100.01% 172,431
Sept 2024 74.87% 12.37% 9.90% 0.00% 1.55% 1.31% 100.00% 163,854
Jun 2024 74.87% 11.58% 9.95% 0.00% 1.46% 2.15% 100.01% 153,450
Mar 2024 74.88% 9.87% 11.14% 0.00% 1.22% 2.89% 100.00% 135,116
Dec 2023 76.50% 0.00% 9.49% 0.00% 1.14% 12.87% 100.00% 127,449
Sept 2023 76.50% 0.00% 4.39% 0.00% 1.11% 18.00% 100.00% 134,731
Jun 2023 76.50% 0.00% 4.64% 0.00% 1.02% 17.83% 99.99% 131,918
May 2023 76.50% 0.00% 2.64% 0.00% 4.15% 16.71% 100.00% 402,322
Mar 2023 76.50% 0.00% 2.64% 0.00% 4.15% 16.71% 100.00% 402,322
Sept 2022 79.00% 0.00% 0.00% 0.00% 0.00% 21.00% 100.00% 17
Quarter Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Mar 2026 72.66% 10.24% 14.46% 0.00% 1.39% 1.25% 100.00% 177,606
Dec 2025 72.66% 11.34% 13.25% 0.00% 1.52% 1.23% 100.00% 177,539
Sept 2025 72.67% 12.84% 11.92% 0.00% 1.36% 1.21% 100.00% 170,347
Jun 2025 72.68% 13.07% 11.50% 0.00% 1.52% 1.23% 100.00% 179,549
Mar 2025 72.70% 12.92% 11.48% 0.00% 1.64% 1.26% 100.00% 180,597
Dec 2024 72.71% 13.34% 11.06% 0.00% 1.60% 1.30% 100.01% 172,431
Sept 2024 74.87% 12.37% 9.90% 0.00% 1.55% 1.31% 100.00% 163,854
Jun 2024 74.87% 11.58% 9.95% 0.00% 1.46% 2.15% 100.01% 153,450
Mar 2024 74.88% 9.87% 11.14% 0.00% 1.22% 2.89% 100.00% 135,116
Dec 2023 76.50% 0.00% 9.49% 0.00% 1.14% 12.87% 100.00% 127,449
Sept 2023 76.50% 0.00% 4.39% 0.00% 1.11% 18.00% 100.00% 134,731
Jun 2023 76.50% 0.00% 4.64% 0.00% 1.02% 17.83% 99.99% 131,918
Year Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Mar 2026 72.66% 10.24% 14.46% 0.00% 1.39% 1.25% 100.00% 177,606
Dec 2025 72.66% 11.34% 13.25% 0.00% 1.52% 1.23% 100.00% 177,539
Dec 2024 72.71% 13.34% 11.06% 0.00% 1.60% 1.30% 100.01% 172,431
Dec 2023 76.50% 0.00% 9.49% 0.00% 1.14% 12.87% 100.00% 127,449